Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2AAdenosine Receptor Antagonists for the Treatment of Parkinson’s Disease.

Details

Language :

English

ISSN :

00222623

Volume :

51

Issue :

22

Database :

Supplemental Index

Journal :

Journal of Medicinal Chemistry

Publication Type :

Academic Journal

Accession number :

35490303

Full Text :

https://doi.org/10.1021/jm800851u